Biopharmaceutical leader in the development of treatments for rare diseases
Monitoring the implementation of the Korea-U.S. Free Trade Agreement, as it relates to transparency in Korean government coverage and reimbursement of biologics. S. 2236: Advancing Breakthrough Therapies for  Patients Act.
H.R. 5651: Food and Drug Administration Reform Act of 2012. 
S. 3187:  Food and Drug Administration Safety and Innovation Act of 2012.  
H.R. 4132: Faster Access to Specialized Treatments Act. Federal legislative efforts to enhance the security and integrity of the domestic pharmaceutical distribution system.
TRD - Trade (domestic/foreign) HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX